Resources Archive - Page 45 of 47

Establishment of KRAS-G12C inhibitor induced resistant tumor models enable the development of new generation KRAS-G12C...

Activating KRAS mutations, including G12C and G12D, are detected in approximately 25% of human cancers. The most common KRAS mutation...

Bifunctional Molecules: A Diverse New Modality That Unlocks New Target Classes

How Diversity In Therapeutic Strategies Is Expanding The Drug Discovery Toolbox

Outsourcing Drug Discovery and Development: Considerations For Emerging Biopharma Companies

Quantum Mechanics for Organic Chemists: An Experimentalist Approach

Magical Power of Quantum Mechanics EBook Would you like to predict organic reaction outcomes accurately? Design synthetic sequences with higher rate...

Targeted Protein Degradation Platform

Integrated Services BIOLOGY & PHARMACOLOGY BINARY/TERNARY COMPLEX FORMATION Biochemical & Biophysical Assays Biochemical binding assay Cellular Assays TARGET UBIQUITINATION &...

Antibody and Protein Preparation Services

Integrated Drug Discovery Platform for Antibody & Protein Preparation We are dedicated to offering an integrated and cost-effective services platform...

Open Access to DEL for data sharing – DELopen

DELopen platform is dedicated to the development and application of DEL technology in drug discovery. Free access to DEL, data...

DEL Screening – DELight Handbook

DEL Screening | WuXi AppTec DELight Kit Faster and Lighter Drug Discovery DELight kit containing 58 libraries and 10.8 billion...

Knowledge Library